Led by investigators of the Vall d’Hebron Institute of Oncology’s (VHIO) Experimental Hematology Group and the Advanced Therapies Program of…
CAR T-cell therapy
Co-authored by Pere Barba, a Lead Investigator of VHIO’s Experimental Hematology Group, results of a study published in Cancer Discovery…
CAR T-cell therapy consists of targeted immune system cell modification to attack the cells that produce the antibodies causing the…
